Board Membership

Chairperson: Dr. W. Craig Vanderwagen, M.D., RADM USPHS - Retired

Dr. Craig Vanderwagen is a senior partner with Martin, Blanck, and Associates who joined the firm on November 1, 2009. His most recent assignment prior to joining MBA was the Assistant Secretary for Preparedness and Response for the US Department of Health and Human Services. He has special interests and experience in bio defense, domestic disaster preparedness and response, international humanitarian and disaster response, federal health delivery systems, innovative organization development and evaluation, and cross cultural health care. From August, 2006 until July, 2009, Dr. Vanderwagen was the founding Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services. In this role he was responsible for the leadership and development of a new organization whose mission was preparing the Nation for response and recovery from public health and other health disasters whether natural or manmade. The organization was initiated after hurricane Katrina and formalized after the passage of the Pandemic and All Hazards Preparedness Act. The Act empowered the ASPR as the lead for all federal public health and medical response in disasters. It also initiated the Biomedical Acquisition, Research, and Development Authority for the development and acquisition of medical countermeasures (preventives, treatments, and diagnostics) for the civilian population. Lastly the funding of grants for development of state and local hospital preparedness activities became a major element of the preparedness activities in ASPR.

Dr. Vanderwagen had a distinguished 28 year career in public service as a commissioned officer in the United States Public Health Service (USPHS), Department of Health and Human Services (HHS). His assignments prior to becoming Assistant Secretary included many deployments in disaster environments. These included lead federal health official in Louisiana after Katrina from August-November, 2005; lead public health official and senior officer aboard the USNS Mercy in Indonesia after the tsunami in 2005;  Director of Primary Care and Public Health for the Ministry of Health in Iraq from September 2003-March, 2004; consultant to the Pan American Health Organization in Honduras after Hurricane Mitch in 1999; and Medical Director for Project Provide Refuge (joint DOD-HHS Kosovar refugee assistance) in 1999.  These deployed assignments however were in addition to his regular duties in the Indian Health Service where during his 25 years of service, he held a number of responsible positions and was the agency’s Chief Medical Officer as his last assignment. During his career with Indian Health Service, Dr. Vanderwagen provided leadership in the uses of electronic health records, implementation of the use of best practices to combat chronic diseases, and was an early supporter of, and the agency’s lead negotiator for a majority of the early Self Governance Compacts. Dr. Vanderwagen is a family physician who believes passionately in the union of public health and clinical medicine. He and his wife of 38 years have 3 grown sons and one granddaughter.


Dr. Luis Barreto

Dr. Luis Barreto is the President of Dr. Luis Barreto & Associates, a consultancy firm specializing in vaccine development, immunization, science policy, global health and biotechnology. He currently works as a Special Advisor to the Vaccine Program, Human Health Therapeutics with the National Research Council (NRC). He is also a Senior Advisor to the Advanced Medical Research Institute of Canada (AMRIC) at Health Sciences North. 

He is the former Vice-President of Clinical, Medical and Regulatory Affairs, Vice-President of Immunization and Science Policy and member of the Senior Management Team at Sanofi Pasteur Canada. He spent more than 23 years in research and development, leading clinical trials, launching vaccines and shaping immunization policy in Canada and around the world.  He was also the Territorial Epidemiologist in the North West Territories. He spent 4 years at the University of Toronto where he completed his Masters of Science in Community Medicine and Epidemiology and four years training towards his Fellowship in Community Medicine. Prior to this Dr Barreto was a lecturer for the Ross Institute of the London School of Hygiene in Bangalore, a lecturer in Community Medicine in Sewagram, India and an Assistant Professor at St. John’s Medical College, in Bangalore, India.

 An influential member of the Canadian vaccine landscape and public health for over 30 years. He has been/is a member of various Government, Academic, Philanthropic and Non Government Organizations Boards and Advisory panels including Research Canada, Health Canada, VIDO/InterVac (Former Chair). PREVENT,  ICAV, FAV, PSAB-NCE, CFI-MAC, CIHR-III, Masters in Science in Global Health at McMaster/Maastricht Universities, a member of the Panel of the Canadian Council of Academies on Human Health Therapeutics for Children and the International Oversight Committee of PCIRN. Dr Barreto was recently appointed as a member of the Board  of International Centre for Infectious Diseases (ICID).

Dr Barreto has been very engaged in Philanthropic and industry association activities in Canada and internationally including Policy and Political support group of the Decade of Vaccines and Saving Lives at Birth initiatives of the Gates Foundation and USAID, UNICEF and GAVI. He has been on various committees of BIOTECanada, Rx &D and IFPMA.  He is member of the Board of March of Dimes and chair of the National Judging Panel of the Sanofi BioGENEius Challenge Canada and an Honorary Patron of Biosciences Education Canada.  He is married to Lorraine and has two boys Rohit and Rahul. 


Ms. Carla Botting

Ms. Carla Botting is the Director of Product Development and Access Unit and Head of the RTS,S Program at the PATH Malaria Vaccine Initiative (MVI) in Washington, DC. Her work involves integrating the needs of developing country health systems into MVI's product development activities, and ensures that vaccines, once developed, will be available and accessible to those in need.

Ms. Botting has more than a dozen years of industry experience in business development and in the development and approval of biologics. Prior to joining MVI, Ms. Botting was the Director of Government Business Development at Cangene Corporation, where she oversaw program management, business development, and government relations with regard to the United States and other industrialized countries. Ms. Botting has worked on joint biological development programs with such partners as the Centers for Disease Control, NIH, the Department of Defense, GSK and the Biomedical Advanced Research and Development Authority. Ms. Botting has served on the Board of Directors of the Alliance for BioSecurity and as a member of the Board of Regents at the University of Winnipeg.

Ms. Botting has an honors degree in commerce from the University of Manitoba and has studied French at the University of Caen in France. She has worked in Russia, Ecuador, and the United Kingdom.


Simon  Brascoupé

Simon  Brascoupé, Anishinabeg/Haudenausanee – Bear Clan is a member of Kitigan Zibi Anishinabeg First Nation, Maniwaki, Quebec. Simon Brascoupé is Adjunct Research Professor at Carleton University Adjunct Professor in the Department of Indigenous Studies at Trent University in Peterborough, Ontario.  He has a B.A. and M.A. from State University of New York at Buffalo, where he is also completing his Ph.D.  He was recently designated Certified First Nations Health Manager (CFNHM) from the First Nations Health Manager Association and a Certified Aboriginal Professional Administrator (CAPA) from the Aboriginal Financial Officers Association of Canada (AFOA). He has a research interest in land based healing, traditional medicine and traditional knowledge.   He conducts research and writes on cultural competency and safety. He published an article “Cultural Safety – Exploring the Applicability of the Concept of Cultural Safety to Aboriginal Health and Community Wellness” in the Journal of Aboriginal Health. He teaches Indigenous Studies at Carleton University.  Previously Simon Brascoupé was Chief Executive Officer, National Aboriginal Health Organization; Director, Primary Health Care Division, First Nations and Inuit Health Branch, Health Canada; and Director, Aboriginal Affairs Branch, Environment Canada. He has written and  worked in the field of traditional knowledge and intellectual Property Rights and is  on Trent University’s Ph.D. Indigenous Knowledge Council.


Dr. Jino Distasio

For over a decade, Dr. Distasio has worked in Winnipeg’s inner city as global urban issues. During this period he has been involved in over 100 research projects, publications and community initiatives. His most recent effort is serving as Co-Principal Investigator in a project examining homelessness and mental health in Canadian cities. This $110 million dollar project is funded by the Mental Health Commission of Canada and is the largest such initiative to be conducted in Canadian history.well as researching Canadian and 

Areas of interest include mental health and homelessness, urban sustainability, quality of life; Aboriginal mobility and housing; downtown revitalization strategies; and urban economic development. In addition to research Jino has actively participated on numerous inner city committees and boards. This has included serving on the Mayor’s Rapid Transit Taskforce, the Zoning Advisory Committee, and the Downtown Housing Strategy. He also helped produce Winnipeg’s first urban Aboriginal housing plan in partnership with the Manitoba Urban Native Housing Association and has twice coordinated undating Winnipeg’s Federal Homelessness Plan. In 2010 he was appointed to the boards of the Westminster Housing Society and Habitat for Humanity. As well he was appointed to the Canadian Commission for the United Nations Educational Scientific and Cultural Organization (UNESCO) as a member of the Natural, Social and Human Sciences Sectoral Commission.

At the national level, Jino has also led several multi-city projects that have examined hidden homelessness, working poverty and most recently he coordinated the development of a national index of neighbourhood distress in Canadian cities. As a faculty member in the Department of Geography, Jino has actively taught on urban issues while also serving as an Adjunct Professor of City Planning at the University of Manitoba where he has taught and supervised graduate students. He is routinely asked to provide both local and national media comment on issues relating to urban change and poverty, transportation, inner city renewal and other civic and urban issues.


Mr. John McMillan

John McMillan holds an honours degree in commerce from Lakehead University and has studied Biotechnology Strategies for Value Creation at Northwestern University Kellogg School of Management Executive Programs.

From 1988-1995, Mr. McMillan served as  Controller at both ABI Biotechnology Inc. and Apotex Fermentation Inc./Rh Pharmaceuticals.  Rh Pharmaceuticals amalgamated with  Cangene Corporation in August of 1995 and John became the General Manager, responsible for the accounting, marketing and sales, human resources, investor relations and licensing and intellectual properties of the company.  During this time, Mr. McMillan was part of a team  involved in the 2001 acquisition of Chesapeake Biological Laboratories of Baltimore, Maryland (now Cangene bioPharma, Inc.) which was a $50 million investment.  Mr. McMillan also headed  the development of a business unit focused on Biodefense and Government Business Development.  This lead to the first significant U.S. Government biodefense contract after September 11, 2001 in excess of $100 million.  From 2003 to July of 2008, Mr. McMillan served as  Vice President of Commercial Development and Corporate Secretary and from July to December of 2008 he served as Special Projects Advisor  at  Cangene Corporation.  Mr. McMillan retired from Cangene in December of 2008.

Mr. McMillan is the Past Chair of the Board for BioTalent Canada in Ottawa, a past advisory board member of the University of Manitoba SmartPark Eureka Project in Winnipeg and a current advisory board member of the Granite Financial Group in Winnipeg.

Currently, Mr. McMillan serves as a part time associate with KWB Chartered Accountants in Winnipeg.


Dr. Mary Pat Moyer

Dr. Mary Pat Moyer is a recognized biomedical scientist, entrepreneur and technology business leader. She founded the innovative life sciences company, INCELL Corporation (1993; www.incell.com), after over 20 years as an academic scientist, as Director of the Center for Human Cell Biotechnology, Division Head of Surgical Research, and Professor of Surgery, Microbiology, Cellular and Structural Biology, Pediatrics, and Molecular Medicine at the University of Texas Health Science Center at San Antonio. She received her Ph.D. in microbiology, emphasis in virology, from the University of Texas at Austin. As a  biology major, she received BS and MS degrees from Florida Atlantic University. Dr. Moyer is an advocate for accelerating development of products from the laboratory to the clinic.


Dr. Andrew Potter

Dr. Andrew Potter is an internationally recognized authority on vaccine development. Dr. Potter is renowned for his visionary research into how bacteria cause disease and for his groundbreaking projects at Vaccine and Infectious Diseases Organization and the University of Saskatchewan that have generated “world firsts” in disease prevention and more than 50 patents for animal vaccine development and therapeutics. He currently runs a successful research program well-funded by competitive grants at the national level. Recently, he has been working on the application of genomics to the animal health field, as well as forging links between the animal and human infectious disease research communities to ensure that technologies common to both fields can be leveraged to their greatest benefit.